Power Pivot excels in handling large datasets and performing complex analytics, using data modeling and DAX expressions, but requires advanced knowledge and proper data preparation. Choosing the right ...
Vladimir Zakharov explains how DataFrames serve as a vital tool for data-oriented programming in the Java ecosystem. By ...
JM Financial warns that Thermax’s aggressive push into asset-heavy segments like solar and bio-CNG could hit EBIT estimates. JM Financial initiated coverage on Thermax with a ‘Reduce’ rating and ...
Investors are looking past headline inflation noise to drive a significant market shift. According to Professor Jeremy Siegel, the current rotation toward small-cap and value stocks is sustainable, ...
While the market fixates on short-term product cycles, Hims & Hers is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personalized ...
Cullinan Therapeutics is a cash-rich clinical-stage biotech with great autoimmune and AML T-cell research, which has promising catalysts for 2026. CGEM also partnered for zipalertinib, which is ...
Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding ...
The Senate Banking Committee won't return to its work on crypto market structure for at least a few weeks, three people familiar with the situation told CoinDesk. After last week's public pull-out by ...
Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding ...
AUSTEDO ® global revenues of $2.26 billion, growing 34% YoY in LC. Increased by 2% in the U.S., decreased by 2% in Europe and decreased by 2% in International Markets, all in LC terms compared to 2024 ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results